Melatonin has for a long time been involved in the photoperiodic control of fish physiology (growth, reproduction) and behavior (locomotor activity); but its mechanisms of action are not understood. We show here that 2-[125I]iodomelatonin binds specifically to membrane preparations from Pike (Esox lucius, L.) pituitaries (KD: 556 pM; Bmax: 2.8 fmol/mg proteins). Radioautography indicated that the binding was restricted to a part of the pituitary only. Using polymerase chain reaction from pike genomic DNA, we subcloned two partial cDNAs encoding the P1.4 (Mel1a) and the P2.6 (Mel1b) melatonin receptor subtypes. The two corresponding transcripts were expressed in the pituitary as revealed by RT-PCR assay and Southern blot hybridization. In culture, melatonin inhibited in a time- and dose-dependent manner cyclic AMP levels in pituitaries cultured in the presence of forskolin, an adenylyl cyclase activator. This is the first evidence for the expression of melatonin receptors and binding sites, and for the modulation of a second messenger by melatonin in the pituitary of a nonmammalian species. We suggest that in fish, the melatonin-mediated photoperiodic control of neuroendocrine functions involves, at least, a direct effect on the pituitary.

1.
Falcón J: Cellular circadian clocks in the pineal. Prog Neurobiol 1999;58:121–162.
2.
Dubocovich ML: Melatonin receptors: Are there multiple subtypes? Trends Pharmacol Sci 1995;16:50–56.
3.
Morgan PJ, Barrett P, Howell HE, Helliwell R: Melatonin receptors: Localization, molecular pharmacology and physiological significance. Neurochem Int 1994;24:101–146.
4.
Ebisawa T, Karne S, Lerner MR, Reppert SM: Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 1994;91:6133–6137.
5.
Reppert SM, Weaver DR, Ebisawa T: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994;13:1177–1185.
6.
Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF: Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995;92:8734–8738.
7.
Reppert SM, Weaver DR, Cassone VM, Godson C, Kolakowski LF Jr: Melatonin receptors are for the birds: Molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron 1995;15:1003–1015.
8.
Liu F, Yuan H, Sugamori KS, Hamadanizadeh A, Lee FJ, Pang SF, Brown GM, Pristupa ZB, Niznik HB: Molecular and functional characterization of a partial cDNA encoding a novel chicken brain melatonin receptor. FEBS Lett 1995;374:273–278.
9.
Barrett P, Conway S, Jockers R, Strosberg D, Guardiola-Lemaitre B, Delagrange P, Morgan PJ: Cloning and functional analysis of a polymorphic variant of the ovine Mel1a melatonin receptor. Biochim Biophys Acta 1997;1356:299–307.
10.
Dubocovich ML, Cardinali DP, Guardiola-Lemaitre B, Hagan RM, Krause DN, Sugden D, Vanhoutte PM, Yocca FD: Melatonin receptors; in Girdlestone D (ed): The IUPHAR Compendium of Receptor Characterization and Classification. London, IUPHAR Media, 1998, pp 188–193.
11.
Gauer F, Schuster C, Poirel VJ, Pévet P, Masson-Pévet M: Cloning experiments and developmental expression of both melatonin receptor Mel1a mRNA and melatonin binding sites in the Syrian hamster suprachiasmatic nuclei. Mol Brain Res 1998;60:193–202.
12.
Reppert SM: Melatonin receptors: Molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 1997;12:528–531.
13.
Godson C, Reppert SM: The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 1997;138:397–404.
14.
Nelson CS, Marino JL, Allen CN: Melatonin receptors active heteromeric G protein coupled Kir3 channels. Neuroreport 1996;7:717–720.
15.
Jockers R, Petit L, Lacroix I, de Coppet P, Barrett F, Morgan PJ, Guardiola B, Delagrange P, Marullo S, Strosberg AD: Novel isoforms of Mel1c melatonin receptors modulating intracellular cyclic guanosine 3′,5′-monophosphate levels. Mol Endocrinol 1997;11:1070–1081.
16.
McArthur AJ, Gillette MU, Prosser RA: Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res 1991;565:158–161.
17.
Vanecek J, Pavlik A, Illnerova H: Hypothalamic melatonin receptor sites revealed by autoradiography. Brain Res 1987;435:359–362.
18.
Gauer F, Masson-Pévet M, Skene DJ, Vivien-Roels B, Pévet P: Daily rhythms of melatonin binding sites in the rat pars tuberalis and suprachiasmatic nuclei: Evidence for a regulation of melatonin receptors by melatonin itself. Neuroendocrinology 1993;57:120–126.
19.
Cassone VM, Brooks DS, Kelm TA: Comparative distribution of 2[125I]iodomelatonin binding in the brains of diurnal birds: Outgroup analysis with turtles. Brain Behav Evol 1995;45:241–256.
20.
Weaver DR, Reppert SM: The Mel1a melatonin receptor gene is expressed in human suprachiasmatic nuclei. Neuroreport 1996;8:109–112.
21.
Gwinner E, Hau M, Heigl S: Melatonin: Generation and modulation of avian circadian rhythms. Brain Res Bull 1997;44:439–444.
22.
Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK, Reppert SM: Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997;19:91–102.
23.
Reiter RJ: Melatonin: The chemical expression of darkness. Mol Cell Endocrinol 1991;79:153–158.
24.
Malpaux B, Daveau A, Maurice-Mandon F, Duarte G, Chemineau P: Evidence that melatonin acts in the premammillary hypothalamic area to control reproduction in the ewe: Presence of binding sites and stimulation of luteinizing hormone secretion by in situ microimplant delivery. Endocrinology 1998;139:1508–1516.
25.
Lincoln GA, Clarke IJ: Photoperiodically-induced cycles in the secretion of prolactin in hypothalamo-pituitary disconnected rams: Evidence for translation of the melatonin signal in the pituitary gland. J Neuroendocrinol 1994;6:251–260.
26.
Maywood ES, Bittman EL, Hastings MH: Lesions of the melatonin- and androgen-responsive tissue of the dorsomedial nucleus of the hypothalamus block the gonadal response of male Syrian hamsters to programmed infusions of melatonin. Biol Reprod 1996;54:470–477.
27.
Zachmann A, Ali MA, Falcón J: Melatonin and its effects in fishes: An overview; in Ali MA (ed): Rhythms in Fishes. New York, Plenum Press, 1992, pp 149–165.
28.
Mayer I, Bornestaf C, Borg B: Melatonin in non-mammalian vertebrates: Physiological role in reproduction? Comp Biochem Physiol [A] 1997;118:515–531.
29.
Dubocovich ML, Takahashi JS: Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina. Proc Natl Acad Sci USA 1987;84:3916–3920.
30.
Rivkees SA, Cassone VM, Weaver DR, Reppert SM: Melatonin receptors in chick brain: Characterization and localization. Endocrinology 1989;125:363–368.
31.
Wiechmann AF, Wirsig-Wiechmann CR: Localization and quantification of high-affinity melatonin binding sites in Rana pipiens retina. J Pineal Res 1991;10:174–179.
32.
Martinoli MG, Williams LM, Kah O, Titchener LT, Pelletier G: Distribution of central melatonin binding sites in the goldfish (Carassius auratus). Mol Cell Neurosci 1991;2:78–85.
33.
Ekstrom P, Vanecek J: Localization of 2-[125I]iodomelatonin binding sites in the brain of the Atlantic salmon, Salmo salar L. Neuroendocrinology 1992;55:529–537.
34.
Khan IA, Thomas P: Melatonin influences gonadotropin II secretion in the Atlantic croaker (Micropogonias undulatus). Gen Comp Endocrinol 1996;104:231–242.
35.
Davies B, Hannah LT, Randall CF, Bromage N, Williams LM: Central melatonin binding sites in rainbow trout (Onchorhynchus mykiss). Gen Comp Endocrinol 1994;96:19–26.
36.
Mazurais D, Brierley I, Anglade I, Drew J, Randall C, Bromage N, Michel D, Kah O, Williams LM: Central melatonin receptors in the rainbow trout: Comparative distribution of ligand binding and gene expression. J Comp Neurol 1999;409:313–324.
37.
Iigo M, Kobayashi M, Ohtani-Kaneko R, Hara M, Hattori A, Suzuki T, Aida K: Characteristics, day-night changes, subcellular distribution and localization of melatonin binding sites in the goldfish brain. Brain Res 1994;644:213–220.
38.
Vanecek J, Klein DC: Melatonin inhibition of GnRH-induced LH release from neonatal rat gonadotroph: Involvement of Ca2+ not cAMP. Am J Physiol 1995;269:85–90.
39.
Kost TA, Theodorakis N, Hugues SH: The nucleotide sequence of the chick cytoplasmic beta-actin gene. Nucleic Acids Res 1983;11:8287–8301.
40.
Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6–13.
41.
Gauer F, Masson-Pévet M, Pévet P: Pinealectomy and constant illumination increase the density of melatonin binding sites in the pars tuberalis of rodents. Brain Res 1992;575:32–38.
42.
Gaildrat P, Ron B, Falcón J: Daily and circadian variations in 2-[125I]-iodomelatonin binding sites in the pike brain (Esox lucius). J Neuroendocrinol 1998;10:511–517.
43.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
44.
Limbird LE: Cell Surface Receptors: A Short Course on Theory and Methods. Boston, Martnus-Nijhoff, 1986.
45.
Shiu SYW, Pang SF: An updated phylogenetic analysis of vertebrate melatonin receptor sequences: Reflection on the melatonin receptor nomenclature by the Nomenclature Subcommittee of the International Union of Pharmacology. Biol Signals Recept 1998;7:244–248.
46.
Smith A, Trudeau VL, Williams LM, Martinoli MG, Priede IG: Melatonin receptors are present in non-optic regions of the brain of a deep-sea fish living in the abscence of solar light. J Neuroendocrinol 1996;8:655–658.
47.
Vanecek J: Cellular mechanisms of melatonin action. Physiol Rev 1998;78:687–721.
48.
Vanecek J, Vollrath L: Melatonin inhibits cyclic AMP and cyclic GMP accumulation in the rat pituitary. Brain Res 1989;505:157–159.
49.
Vacas MI, Sarmiento MI, Cardinali DP: Melatonin increases cGMP and decreases cAMP levels in rat medial basal hypothalamus in vitro. Brain Res 1981;225:207–211.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.